Literature DB >> 3728665

Leg glucose uptake during maximal dynamic exercise in humans.

A Katz, S Broberg, K Sahlin, J Wahren.   

Abstract

Leg glucose uptake (LGU) during submaximal (50% maximal O2 uptake) and maximal dynamic exercise (97%) has been quantified from the product of the leg blood flow and the arterial minus femoral venous glucose concentration. Muscle biopsies were also obtained. During 15 min of submaximal exercise the mean LGU values ranged from 1.07 to 1.25 mmol/min, which demonstrates that LGU was stable under this condition. In contrast, during maximal exercise LGU increased continuously, reaching 2.38 +/- 0.22, 2.95 +/- 0.32, and 3.82 +/- 0.34 mmol/min after 2, 4, and 5.2 min (fatigue), respectively. The mean LGU was negatively related to the mean muscle phosphocreatine content (r = -1.00;P less than 0.01). Intracellular glucose-6-phosphate (G-6-P) and glucose were very low at rest and did not change significantly during submaximal exercise (P greater than 0.05). However, at fatigue G-6-P and glucose increased substantially and were both 8.5 mmol/kg dry muscle (P less than 0.001). These findings demonstrate that during heavy exercise glucose accumulates in the cell probably due to hexokinase inhibition by G-6-P, and thus the rate of glucose utilization appears to be lower than the rate of glucose uptake. It is suggested that 1) LGU during short-term exercise is dependent on the energy state of the muscle and 2) LGU is equal to leg glucose utilization during submaximal exercise but is in excess of utilization during heavy exercise.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3728665     DOI: 10.1152/ajpendo.1986.251.1.E65

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  39 in total

Review 1.  Fatigue during high-intensity intermittent exercise: application to bodybuilding.

Authors:  Charles P Lambert; Michael G Flynn
Journal:  Sports Med       Date:  2002       Impact factor: 11.136

2.  Contraction-mediated glycogenolysis in mouse skeletal muscle lacking creatine kinase: the role of phosphorylase b activation.

Authors:  Abram Katz; Daniel C Andersson; Josephine Yu; Barbara Norman; Marie E Sandstrom; Be Wieringa; Hakan Westerblad
Journal:  J Physiol       Date:  2003-09-08       Impact factor: 5.182

Review 3.  Macronutrient considerations for the sport of bodybuilding.

Authors:  Charles P Lambert; Laura L Frank; William J Evans
Journal:  Sports Med       Date:  2004       Impact factor: 11.136

Review 4.  Plasma glucose metabolism during exercise in humans.

Authors:  A R Coggan
Journal:  Sports Med       Date:  1991-02       Impact factor: 11.136

Review 5.  Muscle microvasculature's structural and functional specializations facilitate muscle metabolism.

Authors:  Yvo H A M Kusters; Eugene J Barrett
Journal:  Am J Physiol Endocrinol Metab       Date:  2015-12-29       Impact factor: 4.310

6.  Effect of adrenaline on glucose kinetics during exercise in adrenalectomised humans.

Authors:  K Howlett; H Galbo; J Lorentsen; R Bergeron; T Zimmerman-Belsing; J Bülow; U Feldt-Rasmussen; M Kjaer
Journal:  J Physiol       Date:  1999-09-15       Impact factor: 5.182

7.  Metabolite patterns related to exhaustion, recovery and transformation of chronically stimulated rabbit fast-twitch muscle.

Authors:  H J Green; S Düsterhöft; L Dux; D Pette
Journal:  Pflugers Arch       Date:  1992-03       Impact factor: 3.657

8.  Glycolytic ATP production estimated from 31P magnetic resonance spectroscopy measurements during ischemic exercise in vivo.

Authors:  H Wackerhage; K Mueller; U Hoffmann; D Leyk; D Essfeld; J Zange
Journal:  MAGMA       Date:  1996 Sep-Dec       Impact factor: 2.310

9.  Fuel substrate turnover and oxidation and glycogen sparing with carbohydrate ingestion in non-carbohydrate-loaded cyclists.

Authors:  A N Bosch; S M Weltan; S C Dennis; T D Noakes
Journal:  Pflugers Arch       Date:  1996-10       Impact factor: 3.657

Review 10.  Physiological bases for the treatment of the physically active individual with diabetes.

Authors:  D H Wasserman; N N Abumrad
Journal:  Sports Med       Date:  1989-06       Impact factor: 11.136

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.